Literature DB >> 10918479

Modification of vascular tone using iNOS under the control of a radiation-inducible promoter.

J Worthington1, T Robson, M Murray, M O'Rourke, G Keilty, D G Hirst.   

Abstract

It may be therapeutically advantageous to alter tumour blood supply specifically. Nitric oxide is a potent vasodilator which is produced in many tissues by the enzyme nitric oxide synthase (NOS). We have transfected cDNA for the inducible isoform of this enzyme (iNOS), under the control of the radiation-inducible promoter WAF1. The activity of the promoter was initially assessed using green fluorescent protein (GFP) in both endothelial cells and rat tail artery segments. Induction of protein expression by 9.5- and 4.5-fold respectively, was observed after a radiation dose of 4 Gy. Artery sections were then transfected with the WAF1/iNOS construct; this gave five-fold induction of iNOS protein after a dose of 4 Gy. The transfected artery was also tested functionally for relaxation, indicative of NO production. One hour after exposure to 4 Gy there was a significant (65%) relaxation of artery segments that had been preconstricted with phenylephrine. This could be partially reversed by the NOS inhibitor nitro-L-arginine. This study demonstrates that we can regulate vascular tone using an X-ray inducible promoter.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918479     DOI: 10.1038/sj.gt.3301224

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  9 in total

Review 1.  Regulatable gene expression systems for gene therapy applications: progress and future challenges.

Authors:  S Goverdhana; M Puntel; W Xiong; J M Zirger; C Barcia; J F Curtin; E B Soffer; S Mondkar; G D King; J Hu; S A Sciascia; M Candolfi; D S Greengold; P R Lowenstein; M G Castro
Journal:  Mol Ther       Date:  2005-08       Impact factor: 11.454

Review 2.  Plasmid engineering for controlled and sustained gene expression for nonviral gene therapy.

Authors:  Ethlinn V B van Gaal; Wim E Hennink; Daan J A Crommelin; Enrico Mastrobattista
Journal:  Pharm Res       Date:  2006-05-26       Impact factor: 4.200

Review 3.  Regulatable gene expression systems for gene therapy.

Authors:  Nuria Vilaboa; Richard Voellmy
Journal:  Curr Gene Ther       Date:  2006-08       Impact factor: 4.391

Review 4.  Current status of tumor radiogenic therapy.

Authors:  Feng-Ling Min; Hong Zhang; Wen-Jian Li
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

5.  [Construction of A eukaryotic expression vector carrying the iNOS gene and its effect on A549 lung cancer cells].

Authors:  Sujuan Ye; Weihan Yang; Yu Wang; Wenjing Ou; Qingping Ma; Wen Zhu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2012-05

Review 6.  Metabolism in atherosclerotic plaques: immunoregulatory mechanisms in the arterial wall.

Authors:  Maria J Forteza; Daniel F J Ketelhuth
Journal:  Clin Sci (Lond)       Date:  2022-03-31       Impact factor: 6.876

7.  Transcriptional Targeting in Cancer Gene Therapy.

Authors:  Tracy Robson; David G. Hirst
Journal:  J Biomed Biotechnol       Date:  2003

8.  Evaluation of p21 promoter for interleukin 12 radiation induced transcriptional targeting in a mouse tumor model.

Authors:  Urska Kamensek; Gregor Sersa; Maja Cemazar
Journal:  Mol Cancer       Date:  2013-11-12       Impact factor: 27.401

9.  Study of the combined treatment of lung cancer using gene-loaded immunomagnetic albumin nanospheres in vitro and in vivo.

Authors:  Hao Zhang; Chen Liang; Xinxin Hou; Ling Wang; Dongsheng Zhang
Journal:  Int J Nanomedicine       Date:  2016-03-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.